Skip Navigation
Menu Search
Liver Cancer

Clinical Trials

If you would like more information on Hepatocellular and Cholangiocarcinoma Clinical Trials offered at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, please contact 1-877-LIVER99 (1-877-548-3799).

Current trial listing:

Hepatocellular Carcinoma

J17136- Feasibility and Efficacy of Neoadjuvant Cabozantinib plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients with Locally Advanced Hepatocellular Carcinoma (HCC)
NCT03299946

J1891- A Randomized, Open-label, Multi-center Phase III Study of Durvalumab  and Tremelimumab as First-line Treatment in Patients with Unresectable  Hepatocellular Carcinoma (HIMALAYA)
NCT03298451

J17189- Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients with Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer
NCT03257761

J18118-The effect of CTLA4/PDL-1 Blockade following drug-eluting bead transarterial chemoembolization (DEB-TACE) in patients with intermediate stage of HCC using Durvalumab (MEDI4736) and Tremelimumab
NCT03638141

Cholangiocarcinoma

J17159- A Phase 1b, Randomized, Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination With Cisplatin Plus Gemcitabine and PEGPH20 in Combination With Atezolizumab and Cisplatin Plus Gemcitabine Compared With Cisplatin Plus Gemcitabine in Hyaluronan-High (HA-high) Subjects with Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma
NCT03267940

J1798-Phase 2 (NCT03250273) Clinical Trial of Entinostat in Combination with Nivolumab for Patients with Previously Treated Unresectable or Metastatic or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
NCT03250273

J17189- Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients with Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer
NCT03257761

Search For Cancer Clinical Trials

 

To schedule an appointment, please call

1-877-LIVER99  |  (1-877-548-3799)